These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9709876)

  • 1. Economic evaluation of rotavirus vaccinations in Finland: randomized, double-blind, placebo-controlled trial of tetravalent rhesus rotavirus vaccine.
    Takala AK; Koskenniemi E; Joensuu J; Mäkelä M; Vesikari T
    Clin Infect Dis; 1998 Aug; 27(2):272-82. PubMed ID: 9709876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomised placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis.
    Joensuu J; Koskenniemi E; Pang XL; Vesikari T
    Lancet; 1997 Oct; 350(9086):1205-9. PubMed ID: 9652561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety, efficacy, and immunogenicity of 2 doses of bovine-human (UK) and rhesus-rhesus-human rotavirus reassortant tetravalent vaccines in Finnish children.
    Vesikari T; Karvonen AV; Majuri J; Zeng SQ; Pang XL; Kohberger R; Forrest BD; Hoshino Y; Chanock RM; Kapikian AZ
    J Infect Dis; 2006 Aug; 194(3):370-6. PubMed ID: 16826486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic impact of immunization against rotavirus gastroenteritis. Evidence from a clinical trial.
    Griffiths RI; Anderson GF; Powe NR; Oliveras E; Herbert RJ; Grant CC; Davidson BL
    Arch Pediatr Adolesc Med; 1995 Apr; 149(4):407-14. PubMed ID: 7704169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human calicivirus-associated sporadic gastroenteritis in Finnish children less than two years of age followed prospectively during a rotavirus vaccine trial.
    Pang XL; Joensuu J; Vesikari T
    Pediatr Infect Dis J; 1999 May; 18(5):420-6. PubMed ID: 10353514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptoms associated with rhesus-human reassortant rotavirus vaccine in infants.
    Joensuu J; Koskenniemi E; Vesikari T
    Pediatr Infect Dis J; 1998 Apr; 17(4):334-40. PubMed ID: 9576390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concurrent oral poliovirus and rhesus-human reassortant rotavirus vaccination: effects on immune responses to both vaccines and on efficacy of rotavirus vaccines. The US Rotavirus Vaccine Efficacy Group.
    Rennels MB; Ward RL; Mack ME; Zito ET
    J Infect Dis; 1996 Feb; 173(2):306-13. PubMed ID: 8568290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of high-dose rhesus-human reassortant rotavirus vaccine in Native American populations.
    Santosham M; Moulton LH; Reid R; Croll J; Weatherholt R; Ward R; Forro J; Zito E; Mack M; Brenneman G; Davidson BL
    J Pediatr; 1997 Oct; 131(4):632-8. PubMed ID: 9386673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of high-dose rhesus-human reassortant rotavirus vaccines--report of the National Multicenter Trial. United States Rotavirus Vaccine Efficacy Group.
    Rennels MB; Glass RI; Dennehy PH; Bernstein DI; Pichichero ME; Zito ET; Mack ME; Davidson BL; Kapikian AZ
    Pediatrics; 1996 Jan; 97(1):7-13. PubMed ID: 8545227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rotaviruses detected by reverse transcription polymerase chain reaction in acute gastroenteritis during a trial of rhesus-human reassortant rotavirus tetravalent vaccine: implications for vaccine efficacy analysis.
    Pang XL; Joensuu J; Hoshino Y; Kapikian AZ; Vesikari T
    J Clin Virol; 1999 Jun; 13(1-2):9-16. PubMed ID: 10405887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rotavirus vaccines and vaccination in Latin America.
    Linhares AC; Bresee JS
    Rev Panam Salud Publica; 2000 Nov; 8(5):305-31. PubMed ID: 11190969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in US children. US Rotavirus Vaccine Efficacy Group.
    Bernstein DI; Glass RI; Rodgers G; Davidson BL; Sack DA
    JAMA; 1995 Apr; 273(15):1191-6. PubMed ID: 7707626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative evaluation of reactogenicity and immunogenicity of two dosages of oral tetravalent rhesus rotavirus vaccine. US Rhesus Rotavirus Vaccine Study Group.
    Dennehy PH; Rodgers GC; Ward RL; Markwick AJ; Mack M; Zito ET
    Pediatr Infect Dis J; 1996 Nov; 15(11):1012-8. PubMed ID: 8933551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of immunogenicity and efficacy of rhesus rotavirus reassortant vaccines in breastfed and nonbreastfed children. US Rotavirus Vaccine Efficacy Group.
    Rennels MB; Wasserman SS; Glass RI; Keane VA
    Pediatrics; 1995 Dec; 96(6):1132-6. PubMed ID: 7491235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy, immunogenicity, and safety of two doses of a tetravalent rotavirus vaccine RRV-TV in Ghana with the first dose administered during the neonatal period.
    Armah GE; Kapikian AZ; Vesikari T; Cunliffe N; Jacobson RM; Burlington DB; Ruiz LP
    J Infect Dis; 2013 Aug; 208(3):423-31. PubMed ID: 23599316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of rotavirus vaccine trials in Finland.
    Vesikari T; Joensuu J
    J Infect Dis; 1996 Sep; 174 Suppl 1():S81-7. PubMed ID: 8752295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of correlation between serum rotavirus antibody titers and protection following vaccination with reassortant RRV vaccines. US Rotavirus Vaccine Efficacy Group.
    Ward RL; Bernstein DI
    Vaccine; 1995 Sep; 13(13):1226-32. PubMed ID: 8578808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concurrent administration of rhesus rotavirus tetravalent (RRV-TV) vaccine with pentavalent diphtheria-pertussis-tetanus-Haemophilus influenzae beta-inactivated polio and hepatitis B vaccines.
    Vesikari T; Joensuu J; Baer M; Käyhty H; Olander RM; Sormunen H; Miettinen A; Ward RL; Guillot T
    Acta Paediatr; 1999 May; 88(5):513-20. PubMed ID: 10426173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost effectiveness of a pentavalent rotavirus vaccine in Oman.
    Al Awaidy ST; Gebremeskel BG; Al Obeidani I; Al Baqlani S; Haddadin W; O'Brien MA
    BMC Infect Dis; 2014 Jun; 14():334. PubMed ID: 24941946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An analysis of rotavirus vaccine reports to the vaccine adverse event reporting system: more than intussusception alone?
    Haber P; Chen RT; Zanardi LR; Mootrey GT; English R; Braun MM;
    Pediatrics; 2004 Apr; 113(4):e353-9. PubMed ID: 15060267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.